USA Flag An official website of the United States government
Official websites use .mil
A .mil website belongs to an official U.S. Department of Defense organization.
Secure .mil websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .mil website. Share sensitive information only on official, secure websites.
 
Home
Technologies Available for Licensing

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil


RECOMBINANT P. VIVAX MEROZOITE PROTEIN-1 P42 VACCINE

In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.


Docket:WRAIR 2001-37

Publication/Issued No.:7,150,875

Publication/Issue Date:2006-12-19

Categories: Method

More Detail:Visit USPTO.GOVExternal link

Lab:WRAIR

Inventor(s):LANAR

For Licensing Opportunities, please contact the ORTA at USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil
 
 

Page last modified: 16 Mar 2026

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at:
USArmy.Detrick.MEDCOM-USAMRMC.List.ORTA@health.mil or by telephone at (301)619-2736.